Atrium Therapeutics, Inc.
USD12.29
+0.53 (+4.51%)
CEO
Kathleen Gallagher
IPO Date
2026-02-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.80
Prev. Close
$11.76
Day Low
$11.64
Day High
$12.35
52W Low
$11.40
52W High
$16.77
Market Cap
$0.21B
Volume
0.18M
| 2,878 |
| $72.45 |
| 23 Jan 2026 | Boyce Sarah | director, officer: President and CEO | S-Sale | Disposed | 7,993 | $72.45 |
| 23 Jan 2026 | Boyce Sarah | director, officer: President and CEO | S-Sale | Disposed | 6,394 | $72.45 |
| 23 Jan 2026 | Flanagan W. Michael | Chief Scientific Officer | S-Sale | Disposed | 2,558 | $72.45 |
| 23 Jan 2026 | Flanagan W. Michael | Chief Scientific Officer | S-Sale | Disposed | 3,976 | $72.45 |
| 23 Jan 2026 | MacLean Michael F | Chief Financial Officer | S-Sale | Disposed | 2,735 | $72.45 |
| 23 Jan 2026 | MacLean Michael F | Chief Financial Officer | S-Sale | Disposed | 1,807 | $72.45 |
| 23 Jan 2026 | LEVIN ARTHUR A | director | S-Sale | Disposed | 1,758 | $72.45 |
| 23 Jan 2026 | McCarthy Teresa | Chief Human Resources Officer | S-Sale | Disposed | 1,453 | $72.45 |